Free Trial
NASDAQ:EMBC

Embecta (EMBC) Stock Price, News & Analysis

Embecta logo
$14.50 -0.09 (-0.62%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$14.29 -0.21 (-1.45%)
As of 05:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Embecta Stock (NASDAQ:EMBC)

Key Stats

Today's Range
$14.22
$14.69
50-Day Range
$9.28
$14.59
52-Week Range
$9.20
$21.48
Volume
496,209 shs
Average Volume
720,331 shs
Market Capitalization
$848.11 million
P/E Ratio
10.14
Dividend Yield
4.14%
Price Target
$19.00
Consensus Rating
Moderate Buy

Company Overview

Embecta Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
95th Percentile Overall Score

EMBC MarketRank™: 

Embecta scored higher than 95% of companies evaluated by MarketBeat, and ranked 57th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Embecta has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Embecta has only been the subject of 2 research reports in the past 90 days.

  • Read more about Embecta's stock forecast and price target.
  • Earnings Growth

    Earnings for Embecta are expected to grow by 7.72% in the coming year, from $2.85 to $3.07 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Embecta is 10.14, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.74.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Embecta is 10.14, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 31.27.

  • Price to Earnings Growth Ratio

    Embecta has a PEG Ratio of 0.81. PEG Ratios below 1 indicate that a company could be undervalued.

  • Percentage of Shares Shorted

    5.73% of the float of Embecta has been sold short.
  • Short Interest Ratio / Days to Cover

    Embecta has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Embecta has recently decreased by 11.90%, indicating that investor sentiment is improving significantly.
  • Dividend Leadership

    Embecta is a leading dividend payer. It pays a dividend yield of 4.11%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Embecta does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Embecta is 41.96%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Embecta will have a dividend payout ratio of 19.54% next year. This indicates that Embecta will be able to sustain or increase its dividend.

  • Read more about Embecta's dividend.
  • Percentage of Shares Shorted

    5.73% of the float of Embecta has been sold short.
  • Short Interest Ratio / Days to Cover

    Embecta has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Embecta has recently decreased by 11.90%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Embecta has a news sentiment score of 1.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for Embecta this week, compared to 4 articles on an average week.
  • Search Interest

    4 people have searched for EMBC on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Embecta to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Embecta insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.42% of the stock of Embecta is held by insiders.

  • Percentage Held by Institutions

    93.83% of the stock of Embecta is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Embecta's insider trading history.
Receive EMBC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Embecta and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EMBC Stock News Headlines

embecta to Participate in Investor Events
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.tc pixel
See More Headlines

EMBC Stock Analysis - Frequently Asked Questions

Embecta's stock was trading at $20.65 at the beginning of the year. Since then, EMBC stock has decreased by 29.8% and is now trading at $14.50.

Embecta Corp. (NASDAQ:EMBC) posted its earnings results on Friday, August, 8th. The company reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.35. The firm's revenue for the quarter was up 8.4% on a year-over-year basis.
Read the conference call transcript
.

Top institutional investors of Embecta include American Century Companies Inc. (8.89%), River Road Asset Management LLC (5.54%), Yacktman Asset Management LP (4.06%) and William Blair Investment Management LLC (3.41%). Insiders that own company stock include Devdatt Kurdikar, David F Melcher, Jacob Elguicze, Jeffrey Z Mann and Milton Mayo Morris.
View institutional ownership trends
.

Shares of EMBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Embecta investors own include Waste Connections (WCN), AU Optronics (AUOTY), The RMR Group (RMR), DiamondRock Hospitality (DRH), American Water Works (AWK), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Record date for 6/13 Dividend
5/28/2025
Ex-Dividend for 6/13 Dividend
5/28/2025
Dividend Payable
6/13/2025
Last Earnings
8/08/2025
Today
8/29/2025
Record date for 9/15 Dividend
8/29/2025
Ex-Dividend for 9/15 Dividend
8/29/2025
Dividend Payable
9/15/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:EMBC
CIK
1872789
Fax
N/A
Employees
2,100
Year Founded
N/A

Price Target and Rating

High Price Target
$25.00
Low Price Target
$12.00
Potential Upside/Downside
+31.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.43
Trailing P/E Ratio
10.14
Forward P/E Ratio
5.09
P/E Growth
0.81
Net Income
$78.30 million
Net Margins
7.58%
Pretax Margin
9.10%
Return on Equity
-23.40%
Return on Assets
14.46%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.47
Quick Ratio
1.78

Sales & Book Value

Annual Sales
$1.12 billion
Price / Sales
0.76
Cash Flow
$3.32 per share
Price / Cash Flow
4.37
Book Value
($11.45) per share
Price / Book
-1.27

Miscellaneous

Outstanding Shares
58,490,000
Free Float
58,239,000
Market Cap
$848.11 million
Optionable
Optionable
Beta
1.08
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:EMBC) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners